All News #Library
Biotech
60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19
12 Oct 2023 //
GLOBENEWSWIRE
60 Degrees Pharma withdraws mid-stage study application for COVID drug
18 Sep 2023 //
REUTERS

Market Place
Sourcing Support